Tamera J. Corte

机构：The University of Sydney, Royal Prince Alfred Hospital, UNSW Sydney, Pulmonary Fibrosis Foundation, National Health and Medical Research Council · ORCID：0000-0002-5076-8929

发表论文 230 篇 · 总被引 11716 次 · h-index 50

代表论文

• ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of Associations for Rheumatology (EULAR) Endorsed by the European Reference Network on rare respiratory diseases (ERN-LUNG) (2025 · Annals of the Rheumatic Diseases · 被引 81)
• Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial (2024 · American Journal of Respiratory and Critical Care Medicine · 被引 62)
• ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease (2025 · European Respiratory Journal · 被引 48)
• Global epidemiology and burden of interstitial lung disease (2025 · The Lancet Respiratory Medicine · 被引 46)
• Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project (2024 · Arthritis & Rheumatology · 被引 41)
• Sarcopenia in interstitial lung disease (2024 · European Respiratory Review · 被引 21)